Harpoon Therapeutics Announces Up to $150 Million Private Placement
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2023 -- Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it has entered into a...